[VIEW] agent=Finance & Treasury Business Partner | scenario_id=18 | rounds=20

--- Round 0 ---
[R0.1] Collateral Operations Lead (speak, public): To assess the feasibility of the expanded clearing model, can we discuss the expected margin levels and their potential volatility?
[R0.2] Derivatives Market Risk Lead (speak, public): The initial margin forecast for the next 30 days is $3,400,000,000 on average, with a 95th percentile of $4,100,000,000. We've also observed that a +100 bp parallel move in rates increases initial margin by $520,000,000. To better understand the operational feasibility, can you share the operational timing and processing constraints for collateral transformation, as well as the pool of eligible assets that can be converted into deliverable collateral?
[R0.3] Finance & Treasury Business Partner (speak, public): To address the operational feasibility, our repo and collateral transformation capacity stands at $2,000,000,000 max with a UST haircut of 2.5%. I'd like to understand how the $520,000,000 increase in initial margin due to a +100 bp parallel move in rates aligns with your stress testing scenarios. Also, have we considered the potential impact on our liquidity metrics, given our current LCR is 117% and our target is 110%?

--- Round 1 ---
[R1.1] Collateral Operations Lead (speak, public): Our current operational baseline includes a same-day settlement rate of 97% for an average of 84 margin calls per day. With the expected increase to 113 margin calls per day due to the expanded clearing model, we'll need to ensure our operational processes can scale accordingly. We have $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) available for posting as collateral. Can you help me understand how the stress testing scenarios account for potential tail risks or extreme market movements?
[R1.2] Derivatives Market Risk Lead (speak, public): Our stress testing scenarios include a range of historical and hypothetical market shocks, including a +100 bp parallel rate shift which, as mentioned, results in a $520,000,000 increase in initial margin. We also conduct regular backtesting, with 6 exceptions in the last 250 trading days against an exception threshold of 10, indicating reasonable model performance. To gauge operational readiness, can you confirm if the $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) are readily available for collateral posting, and are there any internal treasury pricing or liquidity floors that could affect our ability to mobilize these assets?
[R1.3] Finance & Treasury Business Partner (speak, public): To confirm, we have $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) that are available for collateral posting. Our liquidity metrics are currently healthy, with an LCR of 117% against a target of 110%. However, we need to consider the impact of increased margin calls on our liquidity. I'd like to highlight that our funding cost assumptions indicate a secured O/N rate at SOFR + 12 bp, and our repo/collateral transformation capacity is capped at $2,000,000,000 with a UST haircut of 2.5%.

--- Round 2 ---
[R2.1] Collateral Operations Lead (speak, public): To better understand the operational feasibility and potential risks, can you clarify if there are any internal treasury constraints or pricing mechanisms that could affect our ability to mobilize the $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) available for collateral posting? Additionally, are there any hidden tail risks or add-ons in the stress testing scenarios that we should be aware of?
[R2.2] Derivatives Market Risk Lead (speak, public): To address the concerns about internal treasury constraints and hidden tail risks, our stress testing scenarios are designed to capture a range of historical and hypothetical market shocks. We've also validated our margin models independently on an annual basis, with the last review showing reasonable performance. To further assess operational readiness, can you confirm if there are any recurring settlement frictions or operational bottlenecks that could impact our ability to meet the increased margin calls?
[R2.3] Finance & Treasury Business Partner (speak, public): To assess operational readiness and potential risks, our current LCR is 117%, above our target of 110%, indicating a healthy liquidity position. However, we need to consider the impact of increased margin calls on our liquidity. I'd like to understand if there are any recurring settlement frictions or operational bottlenecks that could impact our ability to meet the increased margin calls. Additionally, can you confirm if the stress testing scenarios adequately capture potential tail risks or extreme market movements?

--- Round 3 ---
[R3.1] Collateral Operations Lead (speak, public): We've maintained a 97% same-day settlement rate for an average of 84 margin calls per day. With the expected increase to 113 margin calls per day, we're concerned about potential settlement frictions. Can you confirm if the stress testing scenarios adequately capture potential tail risks or extreme market movements that could impact our operational readiness?
[R3.2] Derivatives Market Risk Lead (speak, public): We've assessed the margin risk and operational readiness. To confirm, our initial margin forecast for the next 30 days is $3,400,000,000 on average, with a 95th percentile of $4,100,000,000. We've also observed that a +100 bp parallel move in rates increases initial margin by $520,000,000. Our stress testing scenarios capture a range of historical and hypothetical market shocks. To finalize our assessment, can you confirm if there are any internal treasury pricing or liquidity floors that could affect our ability to mobilize the available collateral?
[R3.3] Finance & Treasury Business Partner (speak, public): To confirm, our liquidity metrics are currently healthy with an LCR of 117% against a target of 110%. However, we need to consider the impact of increased margin calls on our liquidity. I'd like to understand if there are any internal treasury constraints or pricing mechanisms that could affect our ability to mobilize the $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) available for collateral posting.

--- Round 4 ---
[R4.1] Collateral Operations Lead (speak, public): To finalize our assessment, I need to confirm if there are any internal treasury constraints or pricing mechanisms that could affect our ability to mobilize the available collateral. Additionally, can you clarify if the stress testing scenarios adequately capture potential tail risks or extreme market movements that could impact our operational readiness?
[R4.2] Derivatives Market Risk Lead (speak, public): To finalize our assessment, our stress testing scenarios are designed to capture a range of historical and hypothetical market shocks, including a +100 bp parallel rate shift. We've also validated our margin models independently on an annual basis, with the last review showing reasonable performance. To confirm, are there any internal treasury pricing or liquidity floors that could affect our ability to mobilize the $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) available for collateral posting?
[R4.3] Finance & Treasury Business Partner (speak, public): To finalize our assessment, our current LCR is 117%, above our target of 110%, indicating a healthy liquidity position. However, we need to consider the impact of increased margin calls on our liquidity. I've shared our funding cost assumptions and repo/collateral transformation capacity earlier. To confirm, there are no additional internal treasury constraints or pricing mechanisms that could affect our ability to mobilize the $1,800,000,000 in cash and $2,600,000,000 in UST (2-5Y) available for collateral posting, beyond what's already been discussed.

--- Round 5 ---
[R5.1] Collateral Operations Lead (speak, public): Based on the information shared, it appears we have a comprehensive view of the expanded clearing model's operational feasibility. To summarize, we've confirmed the initial margin forecast, stress testing scenarios, and our ability to mobilize collateral. I recommend we approve the expanded central-clearing and collateral-transformation operating model, given our current operational readiness and liquidity position. However, we should continue to monitor settlement frictions and potential tail risks.
[R5.2] Derivatives Market Risk Lead (speak, public): I agree with the recommendation to approve the expanded central-clearing and collateral-transformation operating model, given our current operational readiness and liquidity position. Our stress testing scenarios and margin model governance are robust, and we've confirmed the availability of collateral for posting. Let's continue to monitor settlement frictions and potential tail risks.
[R5.3] Finance & Treasury Business Partner (speak, public): I concur with the recommendation to approve the expanded central-clearing and collateral-transformation operating model. Our current liquidity position is healthy, with an LCR of 117% against a target of 110%. We've also confirmed our ability to mobilize the necessary collateral. Let's continue to monitor settlement frictions and potential tail risks.

--- Round 6 ---
[R6.1] Collateral Operations Lead (leave, public): 
[R6.2] Derivatives Market Risk Lead (leave, public): 
[R6.3] Finance & Treasury Business Partner (leave, public): 

--- Round 7 ---
[R7.1] Collateral Operations Lead (leave, public): 
[R7.2] Derivatives Market Risk Lead (leave, public): 
[R7.3] Finance & Treasury Business Partner (leave, public): 

--- Round 8 ---
[R8.1] Collateral Operations Lead (leave, public): 
[R8.2] Derivatives Market Risk Lead (leave, public): 
[R8.3] Finance & Treasury Business Partner (leave, public): 

--- Round 9 ---
[R9.1] Collateral Operations Lead (leave, public): 
[R9.2] Derivatives Market Risk Lead (leave, public): 
[R9.3] Finance & Treasury Business Partner (leave, public): 

--- Round 10 ---
[R10.1] Collateral Operations Lead (leave, public): 
[R10.2] Derivatives Market Risk Lead (leave, public): 
[R10.3] Finance & Treasury Business Partner (leave, public): 

--- Round 11 ---
[R11.1] Collateral Operations Lead (leave, public): 
[R11.2] Derivatives Market Risk Lead (leave, public): 
[R11.3] Finance & Treasury Business Partner (leave, public): 

--- Round 12 ---
[R12.1] Collateral Operations Lead (leave, public): 
[R12.2] Derivatives Market Risk Lead (leave, public): 
[R12.3] Finance & Treasury Business Partner (leave, public): 

--- Round 13 ---
[R13.1] Collateral Operations Lead (leave, public): 
[R13.2] Derivatives Market Risk Lead (leave, public): 
[R13.3] Finance & Treasury Business Partner (leave, public): 

--- Round 14 ---
[R14.1] Collateral Operations Lead (leave, public): 
[R14.2] Derivatives Market Risk Lead (leave, public): 
[R14.3] Finance & Treasury Business Partner (leave, public): 

--- Round 15 ---
[R15.1] Collateral Operations Lead (leave, public): 
[R15.2] Derivatives Market Risk Lead (leave, public): 
[R15.3] Finance & Treasury Business Partner (leave, public): 

--- Round 16 ---
[R16.1] Collateral Operations Lead (leave, public): 
[R16.2] Derivatives Market Risk Lead (leave, public): 
[R16.3] Finance & Treasury Business Partner (leave, public): 

--- Round 17 ---
[R17.1] Collateral Operations Lead (leave, public): 
[R17.2] Derivatives Market Risk Lead (leave, public): 
[R17.3] Finance & Treasury Business Partner (leave, public): 

--- Round 18 ---
[R18.1] Collateral Operations Lead (leave, public): 
[R18.2] Derivatives Market Risk Lead (leave, public): 
[R18.3] Finance & Treasury Business Partner (leave, public): 

--- Round 19 ---
[R19.1] Collateral Operations Lead (leave, public): 
[R19.2] Derivatives Market Risk Lead (leave, public): 
[R19.3] Finance & Treasury Business Partner (leave, public): 

